# A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine

> **NCT04689191** · PHASE3 · UNKNOWN · sponsor: **Wei Cun** · enrollment: 1280 (estimated)

## Conditions studied

- Meningitis, Meningococcal

## Interventions

- **BIOLOGICAL:** Experimental Group A and C meningococcal polysaccharide vaccine
- **BIOLOGICAL:** Control Group A and C meningococcal polysaccharide vaccine

## Key facts

- **NCT ID:** NCT04689191
- **Lead sponsor:** Wei Cun
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-15
- **Primary completion:** 2021-05
- **Final completion:** 2021-12
- **Target enrollment:** 1280 (ESTIMATED)
- **Last updated:** 2020-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04689191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04689191, "A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04689191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*